shadow_tr

Lymphoma Studies
- - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -

CALGB 51101
A Randomized Phase II Trial of Myeloablative Versus Non-Myeloablative Consolidation Chemotherapy for Newly Diagnosed Primary CNS B-Cell Lymphoma
More Information

Pfizer B9991011
Phase 1B/Phase 3 Multicenter Study of Avelumab (MSB0010718C) in Combination Regimens That Include an Immune Agonist, Epigenetic Modulator, CD20 Antagonist and/or Conventional Chemotherapy in Patients With Relapsed or Refractory Diffuse Large B Cell Lymphoma (DLBCL) B9991011 Javelin DLBCL
More Information

 


 

1430 Tulane Ave, New Orleans, LA 70112 medsch@tulane.edu